Catalyst Wire Dossier Catalyst Wire Dossier

Trelagliptin succinate tablets

trelagliptin succinate · CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Trelagliptin succinate tablets, covering 2021-01-12 to 2021-01-12. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of Trelagliptin Succinate Tablets in the Treatment of Type 2 Diabetes [Phase 3]

See pricing